6-Bromo-2-nitropyridin-3-ol
CAS : 443956-08-9
Ref. 3D-FB75075
5mg | Arrêté | ||
10mg | Arrêté | ||
25mg | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté |
Informations sur le produit
- 2-Nitro-3-Hydroxy-6-Bromopyridine
- 6-Bromo-2-nitro-pyridin-3-ol
6-Bromo-2-nitropyridin-3-ol (6BNP) is a lead compound that has been shown to inhibit protein synthesis in the intestine. It has high oral bioavailability and can be used as a drug to treat metabolic syndrome, although it is not yet clear whether 6BNP is absorbed into the bloodstream. The discovery of 6BNP was based on its ability to inhibit trypsin, which is an enzyme that plays a role in digestion. These inhibitors are also known as "lead compounds" because they have the potential to be developed into drugs for treatment of diseases such as metabolic syndrome.